Precision Treatment of Advanced Lung Adenocarcinoma With Coexisting EGFR, ALK, and ROS1 Mutations: A Case Report
| dc.contributor.author | Zhang, Yaping | |
| dc.contributor.author | Wang, Hui | |
| dc.contributor.author | Wang, Xiaoyan | |
| dc.contributor.author | Li, Shuai | |
| dc.contributor.author | Fang, Hongming | |
| dc.contributor.department | Medicine, School of Medicine | |
| dc.date.accessioned | 2024-10-21T08:54:26Z | |
| dc.date.available | 2024-10-21T08:54:26Z | |
| dc.date.issued | 2021 | |
| dc.eprint.version | Final published version | |
| dc.identifier.citation | Zhang Y, Wang H, Wang X, Li S, Fang H. Precision Treatment of Advanced Lung Adenocarcinoma With Coexisting EGFR, ALK, and ROS1 Mutations: A Case Report. Clin Lung Cancer. 2021;22(5):e699-e702. doi:10.1016/j.cllc.2021.01.008 | |
| dc.identifier.uri | https://hdl.handle.net/1805/44082 | |
| dc.language.iso | en_US | |
| dc.publisher | Elsevier | |
| dc.relation.isversionof | 10.1016/j.cllc.2021.01.008 | |
| dc.relation.journal | Clinical Lung Cancer | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.source | Publisher | |
| dc.subject | Co-mutation | |
| dc.subject | Driving genes | |
| dc.subject | Multiple gene mutations | |
| dc.subject | Tyrosine kinase inhibitors | |
| dc.title | Precision Treatment of Advanced Lung Adenocarcinoma With Coexisting EGFR, ALK, and ROS1 Mutations: A Case Report | |
| dc.type | Article |